Nombre de sesión Hora Descripción
jueves, 18 de abril de 2024
Think Tank Session (by invitation only)14:00 - 17:00

This invitation only sessions is moderated by Laurence Albiges and James Blackmur and is supported by Pfizer.

Eisai has provided an unrestricted grant for this initiative and has had no influence on the content.

 

Workshop: Cutting-Edge on Kidney: Advanced RCC Surgical Techniques & Team Dynamics for Young Urologists 17:15 - 18:45

Chair: Dr. Lars Lund

 

Program Highlights:

 

Pathway to Renal Surgery: This session will navigate through the career trajectory of a young urologist to becoming a renal surgeon. Gain insights into the necessary training, education, and hands-on experience required to excel in this specialty.

 

Surgical Techniques for Tumor Treatment: Delve into the complexities of various surgical approaches to kidney tumors. This session includes practical tips and tricks to tackle different tumor types, complemented by illustrative video clips to provide a visual learning experience.

 

Team Dynamics in Urology: Discuss the significance of collaboration and team synergy in surgical success. Discover the roles and responsibilities within a surgical team and how to effectively contribute to and lead a team in high-pressure environments.

 

Interactive Case Studies: This interactive session will focus on real-world cases, encouraging participants to engage, discuss, and learn from each other's experiences and perspectives. This workshop is an invaluable opportunity to learn from leading experts, refine your skills, and connect with peers in your field. Secure your spot today and take a significant step toward a successful career in renal surgery.

Pathway to Renal Surgery17:20 - 17:35

Mie Thorlund, MD

Surgical Techniques for Tumor Treatment17:35 - 17:50

Frode Nilssen, MD

Team Dynamics in Urology17:50 - 18:10

Brad Leibovich, MD, Mayo Clinic and Christian Beisland, MD, PhD, University of Bergen

Interactive Case Studies18:10 - 18:45

Panelists: Lars Lund, Mie Thorlund, Frode Nilssen, Brad Leibovich, Christian Beisland

viernes, 19 de abril de 2024
Session 1: Welcome & Indication for Surgery and Surgical Options08:30 - 09:30

Chairs/Moderators: Lars Lund, MD, DMSci, Odense University Hospital and Cristina Suárez Rodriguez, MD, PhD, Vall d’Hebron Hospital Universitari

How to Manage Small Renal Masses08:38 - 08:48

Enrique Trilla, MD, PhD, Vall d’Hebron Hospital Universitari

Presentation slides

Debate: Management of Patients with Positive Partial Nephrectomy Margins08:48 - 09:03

Axel Bex, MD, PhD, The Netherlands Cancer Institute and Arnaud Méjean, MD, PhD

Presentation slides- Bex

Presentation Slides - Mejean

Debate: Adjuvant Therapy for Some or All?09:03 - 09:18

Thomas Powles, MD, MBBS, MRCP, Bart's Cancer Institute and Brian Rini, MD, Vanderbilt University Medical Center

Presentation Slides - Powles

Presentation Slides - Rini

Q & A09:18 - 09:28

Chairs/Moderators: Lars Lund, MD, DMSci, Odense University Hospital and Cristina Suárez Rodriguez, MD, PhD, Vall d’Hebron Hospital Universitari

Session 2: Classifying RCC - A Panel Approach09:30 - 10:30

Chairs/Moderators: Laurence Albiges, MD, PhD, Institut Gustave Roussy and Ignacio Duran, MD, PhD, Hospital Universitario Marques de Valdecilla. IDIVAL

Surgical Approach09:35 - 09:45

Bradley Leibovich, MD, PhD, Mayo Clinic

Presentation Slides

Molecular Approach09:45 - 09:55

Samra Turajilic, MBBS, PhD, The Francis Crick Institute

Presentation Slides

Pathologist Approach09:55 - 10:05

Ferran Algaba Arrea, MD, PhD, Universitat Autònoma de Barcelona

Presentation Slides

Oncologist Approach10:05 - 10:15

Daniel Heng, MD, MPH, FRCPC, Tom Baker Cancer Centre

Presentation Slides

Q & A10:15 - 10:25

Chairs/Moderators: Laurence Albiges, MD, PhD, Institut Gustave Roussy and Ignacio Duran, MD, PhD, Hospital Universitario Marques de Valdecilla. IDIVAL

Break10:15 - 11:00 
Session 3: Pieter de Mulder Award Winner & Lecture10:30 - 10:50

Introduction: Lisa Pickering, MD, Royal Marsden NHS Foundation Trust Award Winner: Manuela Schmidinger, MD, Medical University of Vienna

Presentation Slides - Schmidinger

Session 4: Nonclear Cell RCC11:00 - 12:00

Chairs/Moderators: Michael Staehler, MD, PhD, University of Munich and Ulka Vaishampayan , MBBS, University of Michigan

Papillary RCC - Biology and Treatment11:04 - 11:14

Cristina Suárez Rodriguez, MD, PhD, Vall d’Hebron Hospital Universitari

Presentation Slides

Chromophobe - Biology and Treatment11:14 - 11:24

Martin Voss, MD, Memorial Sloan Kettering Cancer Center

Presentation Slides

Translocation RCC - Biology and Treatment11:24 - 11:34

Daniel Heng, MD, MPH, FRCPC, Tom Baker Cancer Centre

Presentation Slides

FH Deficient Tumors RCC11:34 - 11:44

Yüksel Ürün, MD, Ankara University School of Medicine

Presentation Slides

Q & A11:44 - 11:58

Chairs/Moderators: Michael Staehler, MD, PhD, University of Munich and Ulka Vaishampayan, MBBS, University of Michigan

Session 5: Patient perspective12:00 - 12:15

Presenter: Dawn Dyson Presentation Slides

Presenter: Weronika Wrzesinski Presentation Slides

Session 6: Oral Abstracts12:15 - 13:15

Chairs/Moderators: Cristina Suárez Rodriguez, MD, PhD, Vall d’Hebron Hospital Universitari and David McDermott, MD, Dana-Farber/ Harvard Center - Beth Israel Deaconess Medical Center

ORAL ABSTRACT: An Integrated Clinicopathological-Molecular Classifier Optimizes Risk Stratification of Localised Clear Cell Renal Cell Carcinoma (ccRCC)12:29 - 12:39

Zayd Tippu

Presentation Slides

ORAL ABSTRACT: Exploring and identifying differences in characteristics and outcomes between patients receiving cabozantinib plus nivolumab (CaboNivo) and sunitinib in CheckMate 9ER (CM9ER): a latent class analysis12:39 - 12:49

David Cella

Presentation Slides

ORAL ABSTRACT: Extended follow-up of KEYNOTE-B61: First-line pembrolizumab plus lenvatinib for non–clear cell renal carcinoma (nccRCC)12:49 - 12:59

Martin Voss, MD, Memorial Sloan Kettering Cancer Center

Presentation Slides

ORAL ABSTRACT: Efficacy by baseline characteristics in the phase 3 LITESPARK-005 study of belzutifan versus everolimus for previously treated advanced clear-cell renal-cell carcinoma (ccRCC)12:59 - 13:09

Laurence Albiges, MD, PhD, Institut Gustave Roussy

Presentation Slides

Q & A13:09 - 13:15

Chairs/Moderators: Cristina Suárez Rodriguez, MD, PhD, Vall d’Hebron Hospital Universitari and David McDermott, MD, Dana-Farber/ Harvard Center - Beth Israel Deaconess Medical Center

Posters & Lunch13:15 - 14:30 
Non-CME Industry Symposium: New Treatment Options for locoregional RCC and advanced RCC post-IO and -TKI” – Presented by MSD13:25 - 14:25

Speakers: Daniel Heng, Marc-Oliver Grimm, Cristina Suarez, Eric Jonasch

Session Intro & KCA Updates14:30 - 14:48

Chairs/Moderators: Samra Turajlic, MBBS, PhD, The Francis Crick Institute and Lisa Pickering, MD, Royal Marsden NHS Foundation Trust Presenter: Salvo LaRosa PhD Kidney Cancer Association

KCA LaRosa Presentation Slides

Session 7: Debate: Systemic Therapy14:30 - 15:35

Chairs/Moderators: Samra Turajlic, MBBS, PhD, The Francis Crick Institute and Lisa Pickering, MD, Royal Marsden NHS Foundation Trust

Debate: Combinations of Immune Checkpoint Inhibitors or IO TKI in Intermediate and Poor Risk Patients14:48 - 14:58

Laurence Albiges MD, PhD, Institut Gustave Roussy and Manuela Schmidinger, MD, Medical University of Vienna

Albiges Presentation Slides

Schmidinger Presentation Slides

Debate: IO Containing Therapy vs TKI Monotherapy in Favorable Risk Patients14:58 - 15:08

Cristina Suárez Rodriguez, MD, PhD, Vall d’Hebron Hospital Universitari and Ignacio Duran, MD, PhD, Hospital Universitario Marques de Valdecilla. IDIVAL

Suárez Presentation Slides

Duran Presentation Slides

Debate: What Should be the Comparator Arm for Future First-Line Trials?15:08 - 15:18

Martin Voss, MD, Memorial Sloan Kettering Cancer Center and Bernard Escudier, MD, Institut Gustave Roussy

Voss Presentation Slides

Escudier Presentation Slides

Panel Discussion15:18 - 15:33

Chairs/Moderators: Samra Turajlic, MBBS, PhD, The Francis Crick Institute and Lisa Pickering, MD, Royal Marsden NHS Foundation Trust

Session 8: Management Approaches of Low Volume and Oligometastatic RCC15:35 - 16:30

Chairs/Moderators: Manuela Schmidinger, MD, Medical University of Vienna and Lars Lund, MD, DMSci, Odense University Hospital

The Role of Radiation Therapy in Localized RCC Debate15:39 - 15:49

Xavier Maldonado, MD, PhD, Vall d’Hebron Hospital Universitari

Presentation Slides

Radiation Therapy in Oliogometastic Disease15:49 - 15:59

Raquibul Hannan, MD, PhD, UTSW

Presentation Slides

The Role of Nephrectomy in Metastatic RCC15:59 - 16:09

Arnaud Méjean, MD, PhD, HEGP

Presentation Slides

Treatment of Residual RCC Following First-Line Systemic Therapy16:09 - 16:19

Yüksel Ürün, MD, Ankara University School of Medicine

Presentation Slides

Q & A16:19 - 16:30

Chairs/Moderators: Manuela Schmidinger, MD, Medical University of Vienna and Lars Lund, MD, DMSci, Odense University Hospital

Break--beverages available in the Auditorium Lobby16:30 - 16:40 
Elevated soluble CD163 at baseline and increased PD1 expression on CD8pos T lymphocytes are associated with poor outcome in metastatic renal cell carcinoma.16:40 - 16:42

Mie Wolff Kristensen

Session 9: Oral Poster ad Presentations16:40 - 16:51

Chair: Lars Lund, MD, DMSci, Odense University Hospital

Multi-omics and spatial architecture of antigenic macrophage-CD8+ T cell crosstalk at the core of immune checkpoint blockade (ICB) response in advanced clear-cell renal cell carcinoma (aRCC)16:42 - 16:44

Lisa Kinget

Patient-Derived Kidney Cancer Organoids to Predict Patient Therapeutic Responses16:44 - 16:46

Isaac Toleman

Evaluation of bone response in metastatic renal cell carcinoma treated in 1st line with immunotherapy-based therapy16:46 - 16:48

Fabien Moinard-Butot

Real-world characterization of patients treated with first-line checkpoint inhibitor-based combination therapy for advanced renal cell carcinoma: CARINA study post-hoc analysis16:48 - 16:50

Paul Nathan, MD

Session 10: Women & Allies in RCC16:50 - 17:50

Chair/Moderator: Ulka Vaishampayan, MBBS, University of Michigan

Speaker Ann Francke, CEO of the Chartered Management Institute (CMI) in London and author of Create a Gender-Balanced Workplace, will lead a discussion on the importance of creating gender-inclusive workplaces, including common challenges when doing so and practical solutions to overcoming them. This session is open to both Women in RCC members and anyone who is an ally of this important KCA initiative.

This event is sponsored by Exelixis and Bristol Myers Squibb. Eisai has provided an unrestricted grant for this initiative and has had no influence on the content.

Introduction Slides

Presentation Slides

Session Topic 1 - Determined by Chair16:56 - 17:06 
Session Topic 2 - Determined by Chair17:06 - 17:16 
Session Topic 3 - Determined by Chair17:16 - 17:26 
Q & A17:26 - 17:50

Chair/Moderator: Ulka Vaishampayan, MBBS, University of Michigan

Women and Allies in RCC Networking Reception17:30 - 18:00

Continue the Conversation! Join Women in RCC session speaker Ann Francke, CEO of the Chartered Management Institute (CMI) in London and author of Create a Gender-Balanced Workplace, and other Women in RCC members for an informal networking session on Friday from 17:55-18:15. This networking is open to Women in RCC members and any woman who is an ally of this important KCA initiative, but registration is required.

This event is sponsored by Exelixis and Bristol Myers Squibb. Eisai has provided an unrestricted grant for this initiative and has had no influence on the content.

 

Evening Reception17:30 - 18:30 
Poster Tour18:05 - 18:25

Chairs: Annika Fendler, PhD, Charité - University Hospital Berlin and Michael Staehler, MD, PhD, University of Munich

Non-CME Industry Symposium: aRCC: Is your decision-making up-to-date? - Presented by Ipsen18:45 - 19:45

Speakers: Prof. James Larkin (UK), Prof. Manuela Schmidinger (Austria), Prof. Laurence Albiges (France), Prof. Camillo Guglielmo Porta (Italy). Presented by Ipsen.

Dine & Connect20:00 - 22:30

Who is invited: All attendees of the conference
When: Friday, April 19, 2024; 20:00 -22:30
Cost: €10 plus VAT.  Non-refundable will hold the reservation and will go to the cost of creating reservations and assigning groups. (Does not include cost of dinner.)
Description: Indulge in an evening of culinary delight and meaningful connections at our exclusive Dine and Connect event during the conference in Sitges. For just €10, secure your spot for an intimate dinner at a carefully selected restaurant, where you'll be randomly grouped with up to 10 fellow attendees. This unique networking opportunity ensures you engage with a diverse range of professionals, fostering new connections and expanding your conference experience beyond the lecture halls. Don't miss this chance to savor delicious cuisine while building valuable relationships—reserve your seat for an unforgettable Friday night on April 19, 2024, from 20:00 to 22:30.
Where: Restaurants within walking distance of the Meliá

Restaurant Options:
ZEKKEI SITGES | SUSHI NIKKEI
Location: Passeig de les Drassanes, 23, 08870 Sitges, Barcelona, Spain
Type of Food: Sushi – Menu available here.
Distance from Hotel: 10 minute walk

CAN LAURY
Location: Av. del Port d'Aiguadolç, 49, 08870 Sitges, Barcelona, Spain
Type of Food: Seafood – Menu available here.
Distance from Hotel: 10 minute walk

L A T ABERNA DEL P UERTO
Location: Av. del Port d'Aiguadolç, 24, 08870 Sitges, Barcelona, Spain
Type of Food: Seafood – Menu available here.
Distance from Hotel: 10 minute walk

PIERRE SITGES
Location: Passeig de les Drassanes, 27, 08870 Sitges, Barcelona, Spain
Type of Food: Variety: meat, fish, sushi, tapas, burgers.– Menu available here.
Distance from Hotel: 10 minute walk

LA PIZZERIA DEL PORT
Location: Passeig de les Drassanes, 32 Port d’Aiguadolç 08870 Sitges
Type of Food: Pizza Menu available here.
Distance from Hotel: 10 minute walk

sábado, 20 de abril de 2024
Young Investigators Breakfast08:30 - 09:30

The Young Investigators Session is an opportunity for early-career healthcare providers to inquire about the different opportunities in the diverse fields of kidney cancer, such as academia, industry, private practice, and translational/basic research. As the leaders in these sectors, you will be asked to discuss your careers and answer questions from the audience.

Moderator: Cristina Suárez Rodriguez, MD, PhD, Vall d’Hebron Hospital Universitari
Panelists: Laurence Albiges, MD, PhD, Institut Gustave Roussy
           Bradley Leibovich, MD, Mayo Clinic
           Annika Fendler, PhD, Charité - University Hospital Berlin
           

This event is sponsored by Pfizer.

Session 12: Welcome to Day 209:40 - 09:50

Bradley Leibovich, MD, Mayo Clinic

Session 12: Molecular Mechanism of RCC09:50 - 10:50

Chairs/Moderators: Annika Fendler, PhD, Charité - University Hospital Berlin and Ignacio Duran, MD, PhD, Hospital Universitario Marques de Valdecilla. IDIVAL

Mouse Models of Kidney Cancer09:54 - 10:04

James Brugarolas, MD, PhD, Harold C. Simmons Comprehensive Cancer Center - UT Southwestern

Presentation Slides

Genetic Tumor Evolution10:04 - 10:14

Samra Turajlic, MBBS, PhD, The Francis Crick Institute

Presentation Slides

Computational Pathology to Enable Precision Medicine in ccRCC10:14 - 10:24

Charlotte Spencer, MBBS, The Francis Crick Institute

Presentation Slides

Resistance to Immunotherapy10:24 - 10:34

David Braun, MD, PhD, Yale School of Medicine

Presentation Slides

Translating Insights from the TME Into Novel Therapies for Kidney Cancer10:34 - 10:44

David McDermott, MD, PhD, Dana-Farber/ Harvard Center - Beth Israel Deaconess Medical Center

Presentation Slides

Q & A10:44 - 10:50

Chairs/Moderators: Annika Fendler, PhD, Charité - University Hospital Berlin and Ignacio Duran, MD, PhD, Hospital Universitario Marques de Valdecilla. IDIVAL

Break10:50 - 11:00 
Development of an EORTC Questionnaire for Quality of Life Assessment in Renal Cell Cancer Patients10:59 - 11:07

Lisa Wintner, PhD, Tirol Kliniken

Presentation Slides

Session 14: Patient Advocacy - Implementation of Programs for Patients and Patient Organizations11:00 - 12:00

Chairs/Moderators: Lars Lund, MD, DMSci Odense University Hospital and Dena Battle, KCCure

Unmet Need: Treating Bones Mets From Questions to Consensus11:02 - 11:10

Berit Eberhard, Charité Comprehensive Cancer Center

Presentation Slides

How to Collect Data From Patient Experience11:10 - 11:18

Juan Carlos Julian

Presentation Slides

Patient Perceptions and Engagement with Statistical Risk Models in RCC11:18 - 11:26

Dena Battle, KCCure

Presentation Slides

Q & A11:26 - 12:00

Chairs/Moderators: Lars Lund, MD, DMSci Odense University Hospital and Dena Battle, KCCure

Vogelzang Award12:00 - 12:20

Introduction: Laurence Albiges, MD, PhD, Institut Gustave Roussy Award Recipient & Lecturer: Bernard Escudier, MD, Institut Gustave Roussy

Introduction Slides

Presentation Slides

Session 16: Novel Therapies/ Stem Cell/ Novel IO Approaches/ Static Session Beyond IO12:20 - 13:05

Chairs/Moderators: Maxine Tran, MD, PhD, FRCS, MBBS, Royal Free Hospital, UCL Division of Surgery and Interventional Science and Guillermo De Velasco, MD, PhD, Lyx Institute of Urology

Beyond First-Line12:24 - 12:34

Lisa Pickering, MD, Royal Marsden NHS Foundation Trust

Presentation Slides

Approvals Coming Soon12:34 - 12:44

Eric Jonasch, MD, MD Anderson Cancer Center

Presentation Slides

Novel Approaches12:44 - 12:54

Andrew Furness, MD, The Royal Marsden

Presentation Slides

Q & A12:54 - 13:05

Chairs/Moderators: Maxine Tran, MD, PhD, FRCS, MBBS, Royal Free Hospital, UCL Division of Surgery and Interventional Science and Guillermo De Velasco, MD, PhD, Lyx Institute of Urology

Posters & Lunch13:05 - 14:20 
Non-CME Industry Symposium: Answering the Unanswered – Presented by Eisai13:15 - 14:15

Speakers: Prof. Thomas Powles, Prof. Laurence Albiges, Prof. Michael Staehler, Prof. Brian Rini

This meeting is organized and sponsored by Eisai, Inc.

Session 17: Practice Changing Papers14:20 - 15:10

Chairs/Moderators: Laurence Albiges, MD, PhD, Institut Gustave Roussy and Ulka Vaishampayan , MBBS, University of Michigan

Paper 1: KN56414:23 - 14:29

Panelist: Laura Bukavina, MD, MPH University Hospital

Presentation Slides

Discussant 114:29 - 14:35

Panelist: Jean-Christophe Bernhard, MD, PhD, Université de Bordeaux

Presentation Slides

Paper 2: Contact 0314:35 - 14:41

Panelist: Kate Young, MBBS, MA, MD, (Res.), MRCP, Royal Marsden NHS Foundation Trust

Presentation Slides

Discussant 214:41 - 14:47

Panelist: Viktor Grünwald MD, PhD, Universitäts­klinikum Essen

Presentation Slides

Paper 3: Cosmic 31314:47 - 14:53

Panelist: Thomas Powles, MD, MBBS, MRC,P NHS Barts Health

Presentation Slides

Discussant 314:53 - 14:59

Panelist: Sylvie Negrier, MD, PhD, UNICANCER

Presentation Slides

Panel Discussion and Q & A14:59 - 15:10

Chairs/Moderators: Laurence Albiges, MD, PhD, Institut Gustave Roussy and Ulka Vaishampayan , MBBS, University of Michigan

The Christopher G. Wood Rising Star Award15:10 - 15:25

Presented by: Bradley Leibovich, MD, Mayo Clinic

Recipient: Rana R. McKay, MD, Associate Professor of Medicine and Urology at the University of California San Diego

Introduction Slides

Presentation Slides

Session 18: WoodFire15:25 - 16:05

Chair/Moderator: Michael Staehler, MD, PhD, University of Munich

Panelists: Axel Bex, MD, PhD, The Netherlands Cancer Institute Camillo Porta, MD, University of Bari 'A. Moro' Christian Beisland, MD, PhD, University of Bergen Sylvie Negrier, MD, PhD, UNICANCER Rana McKay, MD

Chairs Closing & Final Thoughts16:05 - 16:15

Chairs/Moderators: Lars Lund, MD, DMSci, Odense University Hospital and Cristina Suárez Rodriguez, MD, PhD, Vall d’Hebron Hospital Universitari

Zona horaria: (UTC+01:00) Madrid [Cambiar zona horaria]